Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IntegenX Launches New GlobalFiler® Express Cartridges for RapidHIT® System

Published: Tuesday, February 18, 2014
Last Updated: Tuesday, February 18, 2014
Bookmark and Share
IntegenX has completed the Developmental Validation of GlobalFiler Express reagents from Life Technologies on the RapidHIT System in accordance with SWGDAM guidelines.

IntegenX Inc. announced the launch of GlobalFiler® Express cartridges for the RapidHIT™ System, providing DNA profiles with 24-loci in less than two hours with less than five minutes hands-on time. 

The RapidHIT GlobalFiler Express cartridges contain Life Technologies’ NDIS-approved GlobalFiler Express Kit which has all DNA markers commonly used in most international databases, including all markers recommended for inclusion by the CODIS Core Loci Working Group. The RapidHIT GlobalFiler Express cartridges feature a flexible design, allowing operators to run from one to seven samples in a single run, as well as a room temperature cartridge storage protocol.

IntegenX completed the Developmental Validation of the GlobalFiler Express cartridges with the RapidHIT System for buccal swabs with a highly successful CODIS profile generation rate. Completion of Scientific Working Group for DNA Analysis Methods (SWGDAM) Developmental Validation is a key milestone necessary for the commercialization of human DNA identification systems in forensics, law enforcement, defense, homeland security, and intelligence community applications: the RapidHIT is the only Rapid DNA System to have met such a milestone.

In addition to Developmental Validation data for buccal swabs, IntegenX has generated data demonstrating the RapidHIT System readily analyzes samples routinely recovered from crime scenes, such as blood, saliva, and semen. These applications dramatically expand the utility of the RapidHIT System and provide a fast DNA-based crime scene investigation and rapid lead identification capability for the law enforcement, defense, and intelligence communities worldwide. Data will be presented at the 66th Annual AAFS meeting, February 17-22, Seattle, Washington.

“The combination of the extremely high discrimination power of the large GlobalFiler Express multiplex and the capability of an expedited sample-to-answer with RapidHIT DNA technology should be a powerful tool to extend the utility of DNA typing both outside and within the laboratory,” said Bruce Budowle, Ph.D., executive director of the Institute of Applied Genetics at the University of North Texas Health Science Center (UNTHSC).

“We’re thrilled at the full commercial global launch of the RapidHIT GlobalFiler Express cartridges, and the new flexible format that allows operators to decide how many samples to include per run. The Developmental Validation of the GlobalFiler Express cartridges under SWGDAM guidelines is an important milestone. Offering Life Technologies’ most advanced NDIS-approved chemistry on the RapidHIT will be of great value to the US and worldwide forensic communities,” commented Robert Schueren, president and chief executive officer of IntegenX.

“The superior quality of the data obtained from GlobalFiler Express kits has proven to be a transformative solution for forensic labs,” said Nadia Altomare, vice president and general manager, Human Identification, for Thermo Fisher Scientific. “Our partnership with IntegenX brings together the industry’s most powerful chemistry and the leading rapid platform to help forensic laboratories and law enforcement agencies solve and prevent crimes.”

The IntegenX RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in less than two hours. With less than five minutes of hands-on time, an operator can generate up to seven complete DNA profiles. RapidHIT System DNA profiles are completely compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA human identification will have a high impact toward ensuring the safety of our communities.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsample Prep Company IntegenX Inc. Raises $15.6M, Acquires GenVault Corporation
Company announces closing of transaction and a $15.6M round of financing led by Domain Associates with participation from returning investors.
Monday, February 07, 2011
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!